„From App to Bedside - Utility evaluation of Ada-symptom-analysis for detection of familial Mediterranean fever
- Conditions
- E85.0Non-neuropathic heredofamilial amyloidosis
- Registration Number
- DRKS00031084
- Lead Sponsor
- Charité - Universitätsmedizin Berlin
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
For both groups:
- Consent to participate in the research project
- Signed consent to scientific data collection, data storage and data processing
- Understanding of the German language
Group 1:
- Diagnosis of FMF suspected by Ada symptom-analysis
- as well as no confirmed diagnosis of FMF yet
Group 2:
- Medical diagnosis of FMF within the last 5 years before inclusion in this research project
Exclusion Criteria
For both groups:
- Persons incapable of giving consent
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Survey of the time from the onset of initial symptoms to diagnosis and comparison of both patient groups
- Secondary Outcome Measures
Name Time Method - Comparison of both patient groups with regard to medical diagnostic already used and number of visits by a physician regarding diagnosis FMF<br>- Recording of the number of sick days in the last 2 years due to FMF before diagnosis and in the last year before inclusion<br>- Calculation of the cost savings potential when implementing the app as an access authorisation for a quick specialist consultation<br>- Physicians assessment of the benefits of Ada's pre-diagnostic assessment<br>- Reliability of Ada's disease suggestions